Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
154 participants
OBSERVATIONAL
2019-05-30
2024-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
NCT05357781
Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study
NCT01287689
A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
NCT04540497
IA or PE - What is the Best Treatment Option of Steroid Refractory Neurological Autoimmune Diseases
NCT04687332
Study to Evaluate the Effect of XmAb®5871 on Disease Activity in Patients With IgG4-Related Disease (RD)
NCT02725476
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SSc
74 SSc patients aged 18 - 85
IgG4 measurement (non-interventional, just obtaining data from medical records)
IgG4 measurement in mg/dL
Healthy controls
80 Healthy blood-donors aged 18 - 85
IgG4 measurement (non-interventional, just obtaining data from medical records)
IgG4 measurement in mg/dL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IgG4 measurement (non-interventional, just obtaining data from medical records)
IgG4 measurement in mg/dL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Noa Rabinowicz
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Medical Center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MMC-110-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.